Catalent’s Biologics Drug Manufacturing Facility Expansion, Bloomington, Usa

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10687878

  Document Type - Tender Notices

Description - Location : Bloomington, Indiana, USCatalent will invest around $350m to expand its biologic drug manufacturing facility in Bloomington, Indiana.US-based pharmaceutical manufacturer Catalent has proposed to expand its biologic drug manufacturing facil ity in Bloomington, Indiana, to increase its production capabilities.The project was announced in April 2022 and is expected to involve an investment of $350m. It will expand the biologic drug substance and drug product manufacturing capabilities of the Bloomington site.The proposed investment is expected to generate up to 1,000 jobs between 2022 and 2027. Catalent expects to complete the expansion project in 2024.Location of the Bloomington faci

Mt Ref Id - 10687878

Deadline - Dec 31, 2024